<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

<title>COVID-19 Country Reports</title>

<script type="text/javascript">
window.onload = function() {
  var imgs = document.getElementsByTagName('img'), i, img;
  for (i = 0; i < imgs.length; i++) {
    img = imgs[i];
    // center an image if it is the only element of its parent
    if (img.parentElement.childElementCount === 1)
      img.parentElement.style.textAlign = 'center';
  }
};
</script>





<style type="text/css">
body, td {
   font-family: sans-serif;
   background-color: white;
   font-size: 13px;
}

body {
  max-width: 800px;
  margin: auto;
  padding: 1em;
  line-height: 20px;
}

tt, code, pre {
   font-family: 'DejaVu Sans Mono', 'Droid Sans Mono', 'Lucida Console', Consolas, Monaco, monospace;
}

h1 {
   font-size:2.2em;
}

h2 {
   font-size:1.8em;
}

h3 {
   font-size:1.4em;
}

h4 {
   font-size:1.0em;
}

h5 {
   font-size:0.9em;
}

h6 {
   font-size:0.8em;
}

a:visited {
   color: rgb(50%, 0%, 50%);
}

pre, img {
  max-width: 100%;
}
pre {
  overflow-x: auto;
}
pre code {
   display: block; padding: 0.5em;
}

code {
  font-size: 92%;
  border: 1px solid #ccc;
}

code[class] {
  background-color: #F8F8F8;
}

table, td, th {
  border: none;
}

blockquote {
   color:#666666;
   margin:0;
   padding-left: 1em;
   border-left: 0.5em #EEE solid;
}

hr {
   height: 0px;
   border-bottom: none;
   border-top-width: thin;
   border-top-style: dotted;
   border-top-color: #999999;
}

@media print {
   * {
      background: transparent !important;
      color: black !important;
      filter:none !important;
      -ms-filter: none !important;
   }

   body {
      font-size:12pt;
      max-width:100%;
   }

   a, a:visited {
      text-decoration: underline;
   }

   hr {
      visibility: hidden;
      page-break-before: always;
   }

   pre, blockquote {
      padding-right: 1em;
      page-break-inside: avoid;
   }

   tr, img {
      page-break-inside: avoid;
   }

   img {
      max-width: 100% !important;
   }

   @page :left {
      margin: 15mm 20mm 15mm 10mm;
   }

   @page :right {
      margin: 15mm 10mm 15mm 20mm;
   }

   p, h2, h3 {
      orphans: 3; widows: 3;
   }

   h2, h3 {
      page-break-after: avoid;
   }
}
</style>



</head>

<body>
<h1>COVID-19 Country Reports</h1>

<p>Generating COVID-19 projections for various scenarios and countries</p>

<h2>DOWNLOAD</h2>

<h3>Latest analyses</h3>

<p>COVID-19-ANALYSIS-{COUNTRY-CODE}-{TIME-SPAN}-{EXTENDED-ANALYSIS?}-latest.pdf</p>

<h3>Past analyses</h3>

<p>COVID-19-ANALYSIS-{COUNTRY-CODE}-{TIME-SPAN}-{EXTENDED-ANALYSIS?}-{DATE}.pdf</p>

<h2>COUNTRY ANALYSIS</h2>

<ul>
<li>DATA AND PROJECTION PERIODS</li>
<li>REFERENCE FRAME WRT INFECTION DATE</li>
<li><p>UNCERTAINTY BANDS ON PLOTS OF TRUE CASES DENOTE MULTIPLICATIVE VARIATION OF R</p></li>
<li><p>POPULATION</p></li>
<li><p>NATURAL MORTALITY RATE</p></li>
<li><p>INITIAL LOGARITHMIC GROWTH RATE </p></li>
<li><p>INITIAL INCIDENCE</p></li>
<li><p>INITIALLY INFECTED POPULATION </p></li>
<li><p>APPROX. DATE OF FIRST INFECTION </p></li>
<li><p>INITIAL REPRODUCTION NUMBER (EXACT)</p></li>
<li><p>INITIAL REPRODUCTION NUMBER (EXP. GROWTH)</p></li>
<li><p>DURATION OF VIRAL SHEDDING</p></li>
<li><p>AVG. CASE DURATION</p></li>
<li><p>AVG. TIME TO RECOVERY</p></li>
<li><p>AVG. TIME TO RECOVERY (MILD CASES)</p></li>
<li><p>AVG. TIME TO RECOVERY (SEVERE CASES)</p></li>
<li><p>AVG. TIME TO DEATH</p></li>
</ul>

<h3>FIGURES</h3>

<ul>
<li>VACCINATED</li>
<li>REPRODUCTION NUMBER</li>
<li>MORTALITY</li>
<li>INFECTED</li>
<li>INFECTIOUS</li>
<li>INCIDENCE</li>
<li>TOTAL CASES</li>
<li>RECOVERED</li>
<li>SUSCEPTIBLE</li>
<li>IMMUNE</li>
<li>REINFECTIONS</li>
<li>DEATH RATE</li>
<li>DEATHS</li>
<li><p>FORECAST FIGURES</p></li>
<li><p>EFFECTIVELY VACCINATED</p></li>
<li><p>INFECTED AND DEATHS FOR VARIOUS VACCINATION RATES </p></li>
<li><p>CRITICAL AND SEVERE INFECTIONS</p></li>
<li><p>HOSPITAL AND ICU BEDS</p></li>
<li><p>R SEASONAL</p></li>
<li><p>LOCKDOWN FACTOR</p></li>
<li><p>DEATH RATE DUE TO SEASONAL INFLUENZA</p></li>
<li><p>AVG. DEATH RATE OVER LAST PROJECTION YEAR</p></li>
<li><p>DEATHS INCL. CONTRIBUTION DUE TO NATURAL MORTALITY</p></li>
<li><p>NATURAL DAILY DEATH RATE</p></li>
<li><p>COMPARISON WITH SIMULATIONS USING A GIVEN SUBSET OF DATA ONLY</p></li>
</ul>

<h2>EXTENDED ANALYSIS</h2>

<h3>EARLY STAGES</h3>

<ul>
<li>INITIAL LOGARITHMIC GROWTH RATE</li>
<li>INITIAL INCIDENCE</li>
<li>R0 SENSITIVITY</li>
</ul>

<h3>AGE-AVERAGED PARAMETERS</h3>

<ul>
<li>AGE-AVERAGED BETA, GAMMA, DELTA, AND R PARAMETERS</li>
</ul>

<h3>LOG GROWTH RATE</h3>

<ul>
<li>LOG GROWTH RATE</li>
<li>MIN. ACHIEVABLE LAMBDA AT TIME T</li>
</ul>

<h3>CONTROL MEASURES</h3>

<ul>
<li>APPROX. TIME TO HALF I</li>
<li>APPROX. TIME TO FLATTEN I </li>
<li>LOCKDOWN FACTOR</li>
<li>STRINGENCY INDEX</li>
<li>SCHOOL CLOSING</li>
<li>WORKSPACE CLOSING</li>
<li>STAY-AT-HOME REQUIREMENTS</li>
<li>FACIAL COVERINGS</li>
<li>EFFECTIVENESS OF MEASURES</li>
<li>FATIGUE FACTOR</li>
</ul>

<h3>SELF-OSCILLATIONS</h3>

<ul>
<li>IMPULSE RESPONSE</li>
<li>STEP RESPONSE</li>
<li>RAMP RESPONSE</li>
<li>VARIOUS CONSTANT PROJECTION REPRODUCTION NUMBERS </li>
<li>VARIOUS NATURAL IMMUNITY DURATIONS (AT CONSTANT PROJECTION R)</li>
<li>VARIOUS SCALES OF INFECTIOUSNESS DISTRIBUTION (AT CONSTANT PROJECTION R)</li>
<li>LONG-TERM INFECTION PREVALENCE</li>
<li>PHASE SPACE TRAJECTORIES</li>
<li>AVG. FREQUENCY OF PEAKS IN INFECTION PREVALENCE</li>
<li>AVG. FREQUENCY OF PEAKS ABOVE CAPACITY THRESHOLD</li>
<li>LINEAR SPECTRUM (AT CONSTANT PROJECTION R)</li>
</ul>

<h3>FORCED OSCILLATIONS</h3>

<ul>
<li>VARIOUS FREQUENCIES OF FORCING (ABOUT A CONSTANT PROJECTION R)</li>
<li>LONG-TERM INFECTION PREVALENCE</li>
<li>PHASE SPACE TRAJECTORIES</li>
<li>AVG. FREQUENCY OF PEAKS IN INFECTION PREVALENCE</li>
<li>AVG. FREQUENCY OF PEAKS ABOVE CAPACITY THRESHOLD</li>
</ul>

<h3>SEASONAL FORCING</h3>

<ul>
<li>VARIOUS NATURAL IMMUNITY DURATIONS (WITH SAESONAL FORCING ON R)</li>
<li>VARIOUS SCALES OF INFECTIOUSNESS DISTRIBUTION (WITH SAESONAL FORCING ON R)</li>
<li>LONG-TERM RELAXATION OF LOCKDOWN FACTOR (BACK TO NORMAL)</li>
<li>LONG-TERM INFECTION PREVALENCE</li>
<li>PHASE SPACE TRAJECTORIES</li>
<li>AVG. FREQUENCY OF PEAKS IN INFECTION PREVALENCE</li>
<li>AVG. FREQUENCY OF PEAKS ABOVE CAPACITY THRESHOLD</li>
<li>HYPOTHETICAL CASE OF PERSISTENT IMMUNITY</li>
<li>CRITICAL AND SEVERE INFECTIONS</li>
<li>HOSPITAL AND ICU BEDS</li>
</ul>

<h3>LOCKDOWNS</h3>

<ul>
<li>VARIOUS START/EXIT THRESHOLDS FOR LOCKDOWNS </li>
<li>LONG-TERM INFECTION PREVALENCE WITH LOCKDOWNS</li>
<li>PHASE SPACE TRAJECTORIES</li>
<li>AVG. FREQUENCY OF PEAKS IN INFECTION PREVALENCE</li>
<li>AVG. FREQUENCY OF PEAKS ABOVE CAPACITY THRESHOLD</li>
<li>LOCKDOWN START AND END DATES</li>
<li>TOTAL LOCKDOWN DURATION AND COST </li>
<li>OPTIMAL THRESHOLDS</li>
<li>CRITICAL AND SEVERE INFECTIONS</li>
<li>HOSPITAL AND ICU BEDS</li>
</ul>

<h3>VACCINATIONS</h3>

<ul>
<li>VARIOUS PROJECTION VACCINATION RATES</li>
<li>VARIOUS VACCINE-INDUCED IMMUNITY DURATIONS </li>
<li>VARIOUS NATURAL IMMUNITY DURATIONS </li>
<li>VARIOUS LONG-TERM LOCKDOWN RELAXATION FACTORS (NEW NORMAL)</li>
<li>LONG-TERM INFECTION PREVALENCE WITH VACCINATIONS </li>
<li>VACCINE-INDUCED AND NATURAL IMMUNITIES</li>
<li>EFFECTIVE REPRODUCTION NUMBER</li>
<li>PHASE SPACE TRAJECTORIES</li>
<li>AVG. FREQUENCY OF PEAKS IN INFECTION PREVALENCE</li>
<li>AVG. FREQUENCY OF PEAKS ABOVE CAPACITY THRESHOLD</li>
<li>TOTAL COST </li>
<li>HYPOTHETICAL CASE OF NO VACCINATIONS</li>
<li>CRITICAL AND SEVERE INFECTIONS</li>
<li>HOSPITAL AND ICU BEDS</li>
</ul>

<h3>MINORS TESTING + VACCINATIONS</h3>

<ul>
<li>EVERYDAY ANTIGEN TESTING OF MINORS </li>
<li>VARIOUS PROJECTION VACCINATION RATES</li>
<li>LONG-TERM INFECTION PREVALENCE WITH VACCINATIONS AND MINORS&#39; TESTING </li>
<li>VACCINE-INDUCED AND NATURAL IMMUNITIES</li>
<li>EFFECTIVE REPRODUCTION NUMBER</li>
<li>PHASE SPACE TRAJECTORIES</li>
<li>AVG. FREQUENCY OF PEAKS IN INFECTION PREVALENCE</li>
<li>AVG. FREQUENCY OF PEAKS ABOVE CAPACITY THRESHOLD</li>
<li>TOTAL COST </li>
<li>HYPOTHETICAL CASE OF NO VACCINATIONS NOR TESTING</li>
<li>CRITICAL AND SEVERE INFECTIONS</li>
<li>HOSPITAL AND ICU BEDS</li>
<li>CURRENT TESTING RATE AND POSITIVITY RATE</li>
</ul>

<h3>REMOVAL DENSITIES</h3>

<ul>
<li>REMOVAL DENSITIES DUE TO KERMACK VS. NOVEL REMOVAL DENSITIES </li>
<li>DIFFERENCES IN LONG-TERM INFECTION PREVALENCE AND MORTALITY</li>
</ul>

<h3>INFECTION AGE</h3>

<ul>
<li>AGELESS MODEL VS. INFECTION AGE MODEL (W/O WANING IMMUNITY AND VACCINATIONS)</li>
<li>DIFFERENCES IN LONG-TERM INFECTION PREVALENCE AND MORTALITY</li>
<li>COMPARISON WITH THEORETICAL LIMIT ON INFECTION PREVALENCE</li>
</ul>

<h3>WANING IMMUNITY</h3>

<ul>
<li>VARIOUS NATURAL IMMUNITY DURATIONS </li>
<li>COMPARISON WITH PERSISTENT IMMUNITY MODEL </li>
<li>DIFFERENCES IN LONG-TERM INFECTION PREVALENCE AND NUMBER OF REINFECTION CASES</li>
<li>DECLINE IN RECOVERED AND IMMUNE FOR COMPARISON WITH EXPERIMENTAL STUDIES</li>
</ul>

<h3>MINIMUM PREVALENCE</h3>

<ul>
<li>LOWER LIMIT ON INFECTION PREVALENCE </li>
<li>COMPARISON WITH MODEL W/O LIMIT</li>
<li>DIFFERENCES IN LONG-TERM INFECTION PREVALENCE AND NUMBER OF REINFECTION CASES</li>
</ul>

<h3>DETECTION PROBABILITY</h3>

<ul>
<li>VARIOUS PROBABILITIES OF DIAGNOSIS GIVEN SYMPTOMS</li>
<li>DIFFERENCES IN LONG-TERM INFECTION PREVALENCE </li>
</ul>

<h3>CONTACT TRACING</h3>

<ul>
<li>VARIOUS CUTOFFS ON INFECTIOUSNESS DISTRIBUTION </li>
<li>WITH AND W/O RELAXING THE LOCKDOWN FACTOR (NEW NORMAL)</li>
<li>DIFFERENCES IN LONG-TERM INFECTION PREVALENCE </li>
<li>PERFECT CONTACT TRACING</li>
</ul>

<h3>VARIANTS</h3>

<ul>
<li>VARIOUS DATES OF FIRST APPEARANCE OF VARIANT (W/O IMMUNITY ESCAPE)</li>
<li>VARIOUS MULTIPLICATIVE ADVANTAGES </li>
<li>FIXED MULTIPLICATIVE ADVANTAGE</li>
<li>DIFFERENCES IN LONG-TERM INFECTION PREVALENCE FOR VARIANT AND ORIGINAL STRAIN </li>
</ul>

<h3>VALIDITY</h3>

<ul>
<li>COMPARISON WITH THEORETICAL FINAL SIZE (FOR PERSISTENT IMMUNITY AND W/O VACCINATIONS)</li>
<li>VARIOUS MODEL CHECKSUMS AND DISCREPANCY WITH OBSERVED DATA </li>
</ul>

<h2>COUNTRY COMPARISONS</h2>

<h3>SCENARIOS</h3>

<ul>
<li>COUNTRY COMPARISONS FOR EACH SCENARIO</li>
</ul>

<h3>EARLY STAGES</h3>

<ul>
<li>INITIAL LOGARITHMIC GROWTH RATE</li>
<li>INITIAL INCIDENCE</li>
<li>INITIAL REPRODUCTION NUMBER</li>
</ul>

<h2>SCENARIO COMPARISONS</h2>

<h3>CURRENT COUNTRY</h3>

<ul>
<li>SCENARIO COMPARISONS FOR CURRENT COUNTRY</li>
</ul>

<!-- Global site tag (gtag.js) - Google Analytics -->

<script async src="https://www.googletagmanager.com/gtag/js?id=G-CTEQ2C7JBB"></script>

<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-CTEQ2C7JBB');
</script> 
  

</body>

</html>
